News

Why Delta 8 Carts By Exhale Are This Year’s Best Pick

GLENDALE, Calif., Sept. 05, 2022 (GLOBE NEWSWIRE) -- New users often do not know the difference between Delta 8 and…

2 years ago

Alvotech Reports Update on Initial AVT02 Biologics License Application

REYKJAVIK, Iceland, Sept. 05, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and…

2 years ago

Alvotech Reports Update on Initial AVT02 Biologics License Application

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced…

2 years ago

Orion recalls Devisol Salmiakki dietary supplement from consumers

Devisol_Salmiakki_20mikrog_200tabl Devisol_Salmiakki_20mikrog_200tabl Devisol_Salmiakki_20mikrog_230tabl Devisol_Salmiakki_20mikrog_230tablORION CORPORATION                PRESS RELEASE                 5 SEPTEMBER 2022 AT 8.00 EEST         Orion recalls Devisol Salmiakki dietary supplement from consumers…

2 years ago

Press Release: Evolution of the Board of Directors

Evolution of the Board of Directors Paris, September 5, 2022. The Board of Directors of Sanofi met on September 2,…

2 years ago

Bone Therapeutics to host Extraordinary General Meeting on 05 October 2022

REGULATED INFORMATION As a result of a technical error in the publication dated August 26, 2022, the Board of Directors…

2 years ago

POINT Biopharma Announces Poster Presentation at ESMO Congress 2022 Containing Efficacy & Safety Data from Lead-In Cohort of Phase 3 SPLASH Trial

Poster #1400P will be presented on Sunday, September 11 by Dr. Aaron R. HansenINDIANAPOLIS, Sept. 04, 2022 (GLOBE NEWSWIRE) --…

2 years ago

Affimed To Provide a Clinical Update on AFM24 Monotherapy Dose-escalation at European Society for Medical Oncology (ESMO) Congress 2022

Selected recommended phase 2 dose (RP2D) of 480 mg with ongoing enrollment in disease-specific cohorts; maximum tolerated dose (MTD) not…

2 years ago

Over 480 Million People Estimated to Have COPD, World’s Third Deadliest Disease, ResMed Study Reports

New prevalence figure 22–126% higher than previous estimatesPrevalence expected to reach 592 million by 2050Researchers urge global action on smoking…

2 years ago